Analisa Armstrong MD

PubMed

• 27 citations
  Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years.
  Kristian Reich, Andrew Blauvelt, April W. Armstrong, Richard G. Langley, A. de Vera
  Journal of the European Academy of Dermatology and Venereology. 2019-09-01
• 47 citations
  Patient Perceptions of Clear/Almost Clear Skin in Moderate-to-Severe Plaque Psoriasis: Results of the Clear About Psoriasis Worldwide Survey
  April W. Armstrong, S Jarvis, Wolf-Henning Boehncke, Murlidhar Rajagopalan, Pablo Fernandez-Penas
  Journal of the European Academy of Dermatology and Venereology. 2018-12-01
• 69 citations
  Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results fro...
  Kenneth B. Gordon, April W. Armstrong, Chenglong Han, Peter Foley, Michael Song
  Journal of the European Academy of Dermatology and Venereology. 2018-11-01

Books/Book Chapters

• Oncologic Emergency Medicine: Principles and Practice 
  Chapter: The Acute Abdomen 
  A Armstrong, A FicheraEditors: K. Todd MD & C. Thomas Jr. MD.SpringerEdition 1st,2016

Abstracts/Posters

• Seamguard Preserves Staple Line Histology for Pathological Analysis
  Armstrong A, North Pacific Surgical Association, 1/11/2016

Lectures

• Pancreas Pathology: Neoplasms and Pancreatitis 
  University of Washington - 1/15/2014
• North Pacific Surgical Association 
  1/14/2014
• Chest Trauma and Management 
  University of Washington - 1/28/2013